Treatment of NB cell lines with the chemotherapeutic agent sorafenib corroborates the aforementioned findings, as it blocked the IL-6-induced STAT3 phosphorylation and downstream signaling, inducing apoptosis and cell growth arrest of NB cells [136]. This evidence concerns the gene IL6 and neuroblastoma.